Detailed information for compound 833282

Basic information

Technical information
  • TDR Targets ID: 833282
  • Name: ethyl 2-[3-[(4-methylphenyl)methyl]-2,4-dioxo pyrido[3,2-e]pyrimidin-1-yl]acetate
  • MW: 353.372 | Formula: C19H19N3O4
  • H donors: 0 H acceptors: 4 LogP: 2.22 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)Cn1c(=O)n(Cc2ccc(cc2)C)c(=O)c2c1nccc2
  • InChi: 1S/C19H19N3O4/c1-3-26-16(23)12-21-17-15(5-4-10-20-17)18(24)22(19(21)25)11-14-8-6-13(2)7-9-14/h4-10H,3,11-12H2,1-2H3
  • InChiKey: RCTNJRXWDWDQMX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • ethyl 2-[3-[(4-methylphenyl)methyl]-2,4-dioxo-pyrido[3,2-e]pyrimidin-1-yl]acetate
  • 2-[3-[(4-methylphenyl)methyl]-2,4-dioxo-1-pyrido[3,2-e]pyrimidinyl]acetic acid ethyl ester
  • 2-[2,4-diketo-3-(4-methylbenzyl)pyrido[3,2-e]pyrimidin-1-yl]acetic acid ethyl ester
  • ethyl 2-[3-[(4-methylphenyl)methyl]-2,4-dioxo-pyrido[3,2-e]pyrimidin-1-yl]ethanoate
  • ChemDiv2_007245
  • IDI1_005960

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glycoprotein hormones, alpha polypeptide Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Toxoplasma gondii intraflagellar transport protein 172, putative glycoprotein hormones, alpha polypeptide 116 aa 94 aa 26.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Putative carbonic anhydrase 5 precursor 0.0146 1 1
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0134 0.9115 0.9115
Schistosoma mansoni carbonic anhydrase-related 0.0054 0.3258 0.3258
Echinococcus multilocularis cathepsin b 0.0134 0.9115 0.9115
Echinococcus granulosus carbonic anhydrase II 0.0146 1 1
Trypanosoma cruzi cysteine peptidase C (CPC), putative 0.0134 0.9115 0.8817
Toxoplasma gondii hypothetical protein 0.0054 0.3258 1
Loa Loa (eye worm) hypothetical protein 0.0054 0.3258 0.3258
Brugia malayi Carbonic anhydrase like protein 2 precursor 0.0054 0.3258 0.3258
Echinococcus multilocularis carbonic anhydrase II 0.0146 1 1
Schistosoma mansoni carbonic anhydrase-related 0.0054 0.3258 0.3258
Schistosoma mansoni carbonic anhydrase-related 0.0054 0.3258 0.3258
Echinococcus granulosus carbonic anhydrase 0.0054 0.3258 0.3258
Leishmania major carbonic anhydrase-like protein 0.0146 1 1
Echinococcus multilocularis cathepsin b 0.0134 0.9115 0.9115
Echinococcus granulosus cathepsin b 0.0134 0.9115 0.9115
Giardia lamblia Cathepsin B precursor 0.0044 0.2523 0.5
Echinococcus granulosus cathepsin b 0.0134 0.9115 0.9115
Brugia malayi Carbonic anhydrase like protein 2 precursor 0.0054 0.3258 0.3258
Trichomonas vaginalis Clan CA, family C1, cathepsin B-like cysteine peptidase 0.0044 0.2523 0.5
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.0146 1 1
Plasmodium falciparum carbonic anhydrase 0.0054 0.3258 0.5
Brugia malayi cathepsin B-like cysteine proteinase 0.0134 0.9115 0.9115
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0146 1 1
Giardia lamblia Cathepsin B precursor 0.0044 0.2523 0.5
Echinococcus granulosus carbonic anhydrase 0.0054 0.3258 0.3258
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0134 0.9115 0.9115
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0134 0.9115 0.9115
Trypanosoma cruzi carbonic anhydrase-like protein, putative 0.0146 1 1
Echinococcus multilocularis carbonic anhydrase 0.0054 0.3258 0.3258
Loa Loa (eye worm) hypothetical protein 0.0054 0.3258 0.3258
Echinococcus granulosus carbonic anhydrase 0.0054 0.3258 0.3258
Onchocerca volvulus 0.001 0 0.5
Schistosoma mansoni carbonic anhydrase II (carbonate dehydratase II) 0.0146 1 1
Onchocerca volvulus Bile acid receptor homolog 0.001 0 0.5
Loa Loa (eye worm) carbonic anhydrase 3 0.0146 1 1
Loa Loa (eye worm) eukaryotic-type carbonic anhydrase 0.0146 1 1
Echinococcus multilocularis carbonic anhydrase 0.0054 0.3258 0.3258
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0044 0.2523 0.2523
Onchocerca volvulus Protein ultraspiracle homolog 0.001 0 0.5
Trypanosoma brucei carbonic anhydrase-like protein 0.0146 1 1
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog 0.001 0 0.5
Loa Loa (eye worm) eukaryotic-type carbonic anhydrase 0.0054 0.3258 0.3258
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.0054 0.3258 0.3258
Loa Loa (eye worm) hypothetical protein 0.0134 0.9115 0.9115
Schistosoma mansoni SmCB2 peptidase (C01 family) 0.0134 0.9115 0.9115
Schistosoma mansoni hypothetical protein 0.0054 0.3258 0.3258
Giardia lamblia Cathepsin B precursor 0.0044 0.2523 0.5
Loa Loa (eye worm) cathepsin B 0.0044 0.2523 0.2523
Schistosoma mansoni carbonic anhydrase 0.0054 0.3258 0.3258
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.0054 0.3258 0.3258
Brugia malayi Eukaryotic-type carbonic anhydrase family protein 0.0054 0.3258 0.3258
Echinococcus multilocularis carbonic anhydrase 0.0054 0.3258 0.3258
Loa Loa (eye worm) hypothetical protein 0.0054 0.3258 0.3258

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.5012 uM PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 13.1154 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 29.0929 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.